Open, Non-comparative Pilot Study to Evaluate the Safety and Efficacy of Intraovarian Plasma Rich in Growth Factors (PRGF) in Patients With Low Ovarian Reserve

Recruiting now · Not applicable

Conditions studied: Low Ovarian Reserve

In brief

The use of plasma rich in growth factors (PRGF) improves ovarian reserve markers and IVF laboratory parameters in women with low ovarian reserve. Primary objective To compare ovarian reserve markers and IVF-ICSI laboratory results before and after PRGF infusion. Secondary Objectives * To compare pre- and post-treatment pregnancy rates. * To collect complications associated with the application of intraovarian PRGF. General Outline of the Study VISIT 1 * Patient Selection * Confirm that he/she has all the analyses and variables to be studied. * Signing of Informed Consent * Usual IVF protocol (1st IVF cycle) VISIT 2 * Instillation of intraovarian PRGF on the day of the puncture of the 1st IVF cycle in the FJD VISIT 3 * Analytical control at 4 weeks VISIT 4 * Analytical control at 8 weeks VISIT 5 * In case of failure to achieve gestation Start of 2nd cycle of IVF

Key facts

Study ID

NCT06975683

Run by

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

People needed

50

Starts

2025-05-30

Expected to finish

2026-05-01

Last updated by the study team

2025-06-12

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women of childbearing age as defined by the CTFG*.
• Women in group 3 and 4 of the POSEIDON classification for low reserve:
• POSEIDON 3: patients ˂ 35 years of age with decreased ovarian reserve (AMH <1.2 ng/ml, AFC <5).
• POSEIDON 4: patients ≥ 35 years with decreased ovarian reserve (AMH <1.2 ng/ml, AFC <5).
• Patients with at least one ovary.
• Infertility of more than 1 year duration.
• Provision of safe ovarian access on the day of the puncture.
• They agree to participate and to give their written consent.

You may not qualify if…

• Have a diagnosis of clinical ovarian insufficiency - Patients with an ongoing pregnancy - Patients with a clinical diagnosis of ovarian failure
• Patients with ongoing pregnancy
• Current or previous IgA deficiency,
• Ovarian failure secondary to identified genetic causes.
• Presence of pelvic adhesions after abdominal surgery.
• Chronic use of aspirin, NSAIDs or anticoagulants.
• Diseases that alter platelet number or function.
• Psychiatric disorder that precludes participation in the study (including active substance abuse or dependence).
• Obesity (BMI ≥ 30).
• Current female smokers (≥ 15 cigarettes per day) - Current smoking (≥ 15 cigarettes per day)
• Patients affected by neoplastic disease
• Severe male factor infertility

Where it is running

• Hospital Universitario Fundación Jiménez Diaz — Madrid, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.